Happy Holidays and New year from the EMDB! Please be advised that the EMDB team will be operating at reduced capacity between December 15th - January 12th. With this in mind we would ask that you be prepared for longer reply times through both our helpdesk system and the OneDep deposition system. well done on a productive 2025, wishing you all the best and we will see you in 2026!

EMD-16473

Single-particle
4.41 Å
EMD-16473 Deposition: 19/01/2023
Map released: 10/01/2024
Last modified: 13/11/2024
Overview 3D View Sample Experiment Validation Additional data Links
Overview 3D View Sample Experiment Validation Additional data Links

EMD-16473

SARS-CoV-2 spike in complex with the 17T2 neutralizing antibody Fab fragment (local refinement of RBD and Fab)

EMD-16473

Single-particle
4.41 Å
EMD-16473 Deposition: 19/01/2023
Map released: 10/01/2024
Last modified: 13/11/2024
Overview 3D View Sample Experiment Validation Additional data Links
Sample Organism: Homo sapiens, Severe acute respiratory syndrome coronavirus
Sample: SARS-CoV-2 Omicron Variant Spike Trimer in complex with three 17T2 Fabs
Fitted models: 8c89

Deposition Authors: Modrego A , Carlero D , Bueno-Carrasco MT , Santiago C , Carolis C , Arranz R , Blanco J , Magri G
A monoclonal antibody targeting a large surface of the receptor binding motif shows pan-neutralizing SARS-CoV-2 activity.
PUBMED: 38316751
DOI: doi:10.1038/s41467-024-45171-9
ISSN: 2041-1723
Grant Support: